Clin2
NCT07132671Possibly a fitNot yet recruiting

MRI-guided radiation for prostate cancer recurrence

Prostate Cancer (Post Prostatectomy)

Part of Cancer, Kidney & urinary clinical trials.

This trial tests a precise radiation treatment for prostate cancer that has come back in the prostate bed after surgery, using a special MRI-guided approach to target the spot while protecting nearby organs, which may help delay or stop further cancer growth.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
29 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Your PSA has gone up after prostate surgery, and scans (PET or MRI) show cancer is only in the prostate bed (where the prostate was)
  • The cancer spot is at least 5 mm away from your bladder, rectum, or urinary tube, so it can be safely treated
  • You have not had radiation therapy to that area before
  • You are healthy enough for treatment (able to care for yourself, with adequate blood counts and kidney function)
  • You can have an MRI scan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06508567Recruiting
MRI-Guided Internal Radiation for Returning Prostate Cancer

This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.

Toronto, Ontario
NCT06982469Recruiting
High-dose radiation for prostate cancer return after surgery

This trial tests a high-dose radiation treatment (brachytherapy) that places tiny radioactive seeds directly into the area where your prostate was. It is for men whose prostate cancer has returned only in that area after having their prostate removed.

Pamplona, Foral Community of Navarre
NCT05715502Recruiting
Targeted radiation for prostate cancer that came back

This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.

Poznan, Greater Poland Voivodeship
NCT00913939Recruiting
MRI-guided high-dose-rate treatment for recurrent prostate cancer

This study tests a targeted radiation approach called high-dose-rate (HDR) brachytherapy, guided by MRI, for certain people with recurrent or higher-risk prostate cancer. It may help deliver radiation more precisely, depending on your cancer type and prior treatments.

Toronto, Ontario
NCT03073278Recruiting
Targeted re-radiation for prostate cancer recurrence in one area

This study tests a focused radiation treatment (SBRT) to a small, clearly identified spot in the prostate for men whose prostate cancer has come back after prior external beam radiation. It may help control cancer while limiting radiation to the rest of the prostate and nearby organs.

St Leonards, New South Wales
NCT07142967Recruiting
MR-Linac radiotherapy for prostate cancer that returned after earlier radiation

This trial tests if a special MRI-guided radiotherapy machine (MR-Linac) can safely treat prostate cancer that has come back after previous radiation therapy. It may help men who have limited options and want to avoid more invasive treatments.

New York, New York

Hear when a new Prostate Cancer (Post Prostatectomy) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.